Page 140 - Ciences News Today

PRINCETON, N.J. and BENGALURU, India, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Indegene, a leading global technology-led healthcare solutions provider, announced the fourth edition of Indegene Digital Summit

LONDON and PHOENIX, Ariz., Sept. 13, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced

Bring The Whole Family to the KITS Cubed STEM Fair - And Don't Forget to Pickup Your Free Science Kit!

Smithers, a leading provider of testing, consulting, information, and compliance services, announces the appointment of Dr. Stewart B. Jacobson, DVM, DACVP, as President of the Smithers Environmental

VERNON, BC, Sept. 13, 2022 /CNW/ - Doseology Sciences Inc. , a life sciences company focused on mental health and wellness, is excited to announce that it is attending the CHFA NOW trade show in... | September 13, 2022

Multi-Biomarker Approach Achieves 61 Percent Sensitivity for Cancer at an Overall Specificity of 98.2 Percent in Robust Case-Control Study Including Nearly 600 Cancer Samples Data will

NEW YORK, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug

Interim 12-week analysis from the ongoing Phase 2a trial of an investigational novel gene therapy product, URO-902 (plasmid human cDNA encoding maxi-K channel), receives International Continence

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering

The awards mark Dermavant's fourth and fifth recognitions by Fortune and Great Place to Work Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics